IMC001 / Immunofoco 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IMC001 / Immunofoco
NCT05946226: A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors

Recruiting
1
18
RoW
IMC002 injection, Autologous Claudin 18.2 specific CAR-T cell injection
Suzhou Immunofoco Biotechnology Co., Ltd
Advanced Digestive System Tumor
12/25
12/25

Download Options